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Summary In this report, we investigate several examples of hypoxia-induced drug resistance and compare
them with P-glycoprotein associated multidrug resistance (MDR). EMT6/Ro cells exposed to drugs in air
immediately after hypoxic treatment developed resistance to adriamycin, 5-fluorouracil, and actinomycin D.
However, these cells did not develop resistance to colchicine, vincristine or cisplatin. When the cells were
returned to a normal oxygen environment, they lost resistance. There was no correlation between the content
of adriamycin and the development of adriamycin resistance induced by hypoxia. There was no difference
between the efflux of adriamycin from aerobic cells and that from hypoxia-treated cells. The mRNA for
P-glycoprotein was not detected in the hypoxia-treated cells. These results suggest that hypoxia-induced drug
resistance is different from P-glycoprotein associated multidrug resistance.
As a tumour grows, heterogeneities of cellular microenviron-
ments occur, such as the development of oxygen gradients in
the tumour as a consequence of deficient vascularisation, and
cause hypoxic cells that may be resistant to radiotherapy
(Sutherland, 1988). Several studies using monolayer cultures
(Smith et al., 1980; Teicher et al., 1981, 1985) and the
multicell spheroid system (Sutherland et al., 1979) have sug-
gested that cells under hypoxic conditions or after hypoxic
stress can be resistant to chemotherapy. The development of
resistance to adriamycin and etoposide in Chinese hamster
ovary cells after hypoxia has been shown to correlate with
the induction of oxygen regulated proteins (ORPs) (Shen et
al., 1987; Hughes et al., 1989; Wilson et al., 1989). In this
work, we investigate the effects of hypoxia on the develop-
ment of resistance to various chemotherapeutic agents and
perform experiments to investigate some possible mechanisms
of these effects. Hypoxia-induced drug resistance is compared
with P-glycoprotein associated multidrug resistance (MDR)
(Bradley et al., 1988).
Materials and methods
Cell culture
EMT6/Ro mammary tumour cells were maintained as expo-
nentially growing monolayers in Basal Essential Eagle's
growth media (Gibco) supplemented with 10% foetal bovine
serum in humidified 5% C02/95% air, as described by
Heacock and Sutherland (1986). All experiments were per-
formed on monolayers prepared 24 h in advance by seeding
5 x 105 cells onto 60 mm glass petri dishes. Cells were 60 to
70% confluent at the time of the experiments.
Conditions ofhypoxic exposure
Before being gassed with N2, the cells were supplied with
5 ml of fresh complete medium and allowed to equilibrate in
a humidified 37°C incubator. Cells undergoing hypoxic stress
were isolated in specially designed hypoxic chambers at room
temperature (Sutherland et al., 1982). The chambers were
repeatedly evacuated and filled every 15 min for 2.25 h with
the appropriate gas mixtures certified to contain less than
10 ppm 02. The sealed chambers were then removed to a
warm room (37'C) at a time point, t, referred to hereafter as
'0' hours of hypoxia.
Preparation ofdrugs and conditions ofdrug exposure
All drugs used were obtained from Sigma Chemical Com-
pany. Stock solutions of adriamycin (ADR), vincristine, and
actinomycin D (ACTD) were prepared with phosphate-
buffered saline (PBS). Solutions of 5-fluorouracil (5-FU),
colchicine, and cisplatin were made before each experiment.
The solvents used were PBS for ADR, ACTD and cisplatin
and distilled water for 5-FU. Absolute ethanol was used as a
solvent for colchicine in order to obtain a sufficiently high
concentration for the experiments. The final concentration of
alcohol in the medium was 1%. As a control for the alcohol
solvent, we established that 1% of absolute ethanol in cul-
tures for 2 h had no effect on plating efficiency. Drug treat-
ment was started under aerobic conditions at 37'C in the
incubator after culture dishes were removed from the cham-
bers at the zero time. Exposure times for ADR, ACTD and
cisplatin were 1 h. A 2 h exposure time was used for 5-FU,
colchicine and vincristine to cause significant cell killing.
Exposure times were limited to 1-2 h to avoid the effect of
release from a ORPs-induced state, which results in the loss
of ADR resistance (Shen et al., 1987; Wilson et al., 1989).
After treatment, the cells were harvested from monolayers
with a 0.01% trypsin solution in citrate-buffered saline,
counted, and plated for clonogenic cell survival assays. Each
drug was tested in at least three separate experiments.
Analysis ofcell cycle kinetics
Cell cycle redistribution after various hypoxic exposures was
examined by flow cytometric analysis of nuclei treated with
propidium iodide (Sigma Chemical Company). Cells (1 x 106)
were trypsinised and fixed in 70% ethanol. After treatment
with RNase at 1 mg ml-' for 30 min, the DNA was stained
with propidium iodide at 1Ofig ml-'. Cells were analysed
with an EPICS flow cytometer using laser excitation at
488 nm and a 600 nm wavelength-pass filter for propidium
iodide fluorescence.
ADR content andefflux
The ADR content was determined in cells treated the same
way as those used for clonogenic cell survival. Cells were
exposed to jigml-' of ADR for h after various time
periods of hypoxia, then trypsinised and pelleted at 4°C
(2 x 106 cells/pellet). Cell pellets were frozen at -20C until
analysed. For drug efflux determinations, aerobic control
cells were exposed to 1 gig ml-' of ADR for 1 h while cells
subjected to 12 h of hypoxia were exposed to 3 Lg ml-' of
ADR for 1 h, so that similar levels of ADR content could be
obtained. The cells were washed three times with fresh
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Figure 1 The effect of hypoxia on drug toxicity. a, 1 h exposure
to adriamycin; b, I h exposure to actinomycin D; c, 2 h exposure
to 5-fluorouracil. Aerobic control cells (0); 12 h hypoxia-treated
cells subsequently exposed to drugs in air (@). Each value is the
mean of at least three separate experiments; bars, s.d.
medium, then reincubated. Extraction with 10 M urea was
performed by solubilising the cell pellet in 0.2 ml of the
reagent and incubating for 1 h at 37°C. After the incubation
period, the urea solution was extracted twice with 0.5 ml of
chloroform, the phases were separated by centrifugation at
12,000g for 1 min and the chloroform extracts were com-
bined and evaporated with nitrogen (Streeter et al., 1986).
Figure 2 The effect of hypoxia on drug toxicity. a, 2 h exposure
to colchicine; b, 2 h exposure to vincristine; c, 1 h exposure to
cisplatin. Aerobic control cells (0); 12 h hypoxia-treated cells
subsequently exposed to drugs in air (0). Each value is the mean
of at least three separate experiments; bars, s.d.
HPLC analysis was performed using a 4.6 x 150 mm column
of Altex Ultrasphere octyl. The mobile phase was 70% meth-
anol in 0.05 M phosphoric acid at a flow rate of 1.5 ml min-'.
Fluorometric detection was performed using an Aminco-
Bowman spectrophotofluorometer at an excitation wave-
length of 470 nm and an emission wavelength of 580 nm.
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Table I Comparison between hypoxia-induced drug resistance and
P-glycoprotein-associated drug resistance
P-glycoprotein
-associated Hypoxia-induced
Drug drug resistance drug resistance
Colchicine +
Vincristine +
Adriamycin + +
Actinomycin D + +
5-FU +
Cisplatin
+: Substantial resistance developed in hypoxia-treated cells or
classical multidrug-resistant cells associated with an increase in
P-glycoprotein.
-: Substantial resistance did not develop in hypoxia-treated cells or
classical multidrug-resistant cells associated with an increase in
P-glycoprotein.
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Northern blotting
Northern blotting analysis was performed as described by
Kingston (1988) and Selden (1988). Total RNA was transfer-
red to nitrocellulose membranes (Hybond-C extra, Amer-
sham) which were hybridised with a 32P-labelled cDNA
P-glycoprotein probe (600 bp EcoRI fragment from a pCHPI;
specific activity of 3 x I0O c.p.m. tLg-') isolated from the clas-
sical multidrug-resistant Chinese hamster cell line CHRB30
(Riordan et al., 1985).
Results
EMT6/Ro cells exposed to drugs in 95% air plus 5% CO2
immediately after 12h of hypoxia developed resistance to
ADR, 5-FU, and ACTD. The resistance to ADR was the
most significant among this group of compounds. At 1 fig
ml-', a 35-fold difference in ADR sensitivity was observed
(Figure 1). A concentration of 400ligml1' of 5-FU was
approximately seven times more toxic to aerobic cells than to
hypoxia treated cells, while 12 ytg ml-' of ACTD was approx-
imately five times more toxic to aerobic cells than to hy-
poxia-treated cells (Figure 1). On the other hand, cells
exposed to hypoxia did not develop resistance to colchicine,
vincristine or cisplatin (Figure 2). There was no reduction of
colony forming ability after 12 h of hypoxia. Table I shows a
comparison of drug cross resistance for hypoxia-induced
drug resistance and classical multidrug resistance associated
with increased P-glycoprotein (Bradley et al., 1988). Clearly,
the results for hypoxia-induced drug resistance are different
from those expected for classical multidrug resistance.
The change in drug sensitivity in relation to duration of
hypoxic exposure before drug treatment was investigated.
Prolonged hypoxic exposure resulted in the development of
ADR resistance (Figure 3a). This effect was also observed in
the development of 5-FU resistance (Figure 3b).
When the hypoxia-treated cells were returned to a normal
oxygen environment, they lost resistance (Figure 4). Their
sensitivity to 5-FU reached control levels at 12h. Although
the sensitivity to ADR and ACTD reached control levels at
6h, that for ADR decreased slightly and that for ACTD
increased at 12h.
Single parameter DNA histograms were used to analyse
the effect of different periods of hypoxia on changes in cell
cycle kinetics. Cells subjected to hypoxia showed no
significant changes in cell cycle distribution, compared with
aerobic control cultures during the first 10 h of hypoxia. At
12 h of hypoxia, there was about a 10% decrease in the S
population (Figure 5).
Cells subjected to hypoxia showed no significant changes
in their ADR content during the first 8 h or hypoxia, com-
pared with aerobic control cultures. After 10 h of hypoxia,
ADR content began to decrease and reached a plateau after
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Figure 3 Drug cytotoxicity in EMT6/Ro monolayers exposed to
increasing durations of hypoxia. The time zero result was ob-
tained by drug exposure as soon as the hypoxic procedure was
finished. a, ADR concentration: 1 jgml-'; drug exposure time:
1 h in air;-b, 5-FU concentrations: 400tigml-', drug exposure
time: 2 h in air. Each value is the mean of at least three separate
experiments; bars, s.d.
12 h (Figure 6). The rates of efflux of ADR were similar for
both aerobic cells and hypoxia-treated cells (Figure 7).
Using the standard northern blotting technique, we could
not detect any P-glycoprotein message in either aerobic or
hypoxia-treated EMT6/Ro cells, although we detected the
message of P-glycoprotein in wild type Chinese hamster
ovary cells which have low level of mdr expression.
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Discussion
The study of the phenomenon of drug resistance was
significantly advanced by the discovery of a condition of
multidrug resistance in cells that were selected for resistance
to colchicine. These cells are cross-resistant not only to the
closely related colchicine analogue, colcemid, but also to a
wide array of other drugs (Kartner et al., 1983a,b; Garman et
al., 1983). This mutant, referred to as CHRC5, shows a
phenotype characterised by the overproduction of a mem-
brane-bound 'P-glycoprotein' with a molecular weight of
approximately 170-180 kD. In this report, we present several
examples of the resistance of EMT6/Ro cells exposed to
various cancer chemotherapeutic agents in air immediately
after hypoxia treatment. This survey was performed to
determine whether hypoxia-induced drug resistance shows
characteristics similar to those of the multidrug resistance
associated with P-glycoprotein overexpression. Table I shows
a comparison of cross-resistant drugs for P-glycoprotein-
associated classical multidrug resistance (Bradley et al., 1988)
and hypoxia-induced drug resistance. These patterns of resis-
tance are clearly different. Hughes et al. (1989) also found
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Figure 4 The effect on survival of reoxygenation after 12 h
hypoxia of cells exposed to ADR (0), ACTD (A) and 5-FU
(U). Time 0 refers to 12 h hypoxic exposure with no reoxygena-
tion. The column labelled A represents aerobic control cells.
ADR concentration: I tg ml-'; ACTD concentration: 12 pg
ml-'; 5-FU concentration: 400 jg ml- Each value is the mean
of at least three separate experiments; bars, s.d.
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Figure 6 Content of ADR in EMT6/Ro cells exposed to increas-
ing durations of hypoxia. ADR concentration: 1 pg ml- ; drug
exposure time: 1 h at 37C in air. Each value is the mean of three
separate experiments; bars, s.d.
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Figure 5 DNA histograms of cells after various periods of hypoxia. Control indicates aerobic control cells.
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Figure 7 Efflux of ADR from aerobic control cells (0) and cells
exposed to 12 h hypoxia (0). ADR concentrations: 1 figml-' for
aerobic control cells and 3figml1' for 12 h hypoxia-treated cells;
drug exposure time: 1 h at 37'C in air. The points at 0 time were
obtained from cells taken from the washed pellet immediately
before reincubation at 37°C. Each value is the mean of three
separate experiments.
that hypoxia induced substantial resistance against etoposide,
and partial resistance against vincristine and actinomycin D,
but no resistance against bleomycin or radiation in Chinese
hamster ovary cells.
The mechanism of hypoxia-induced drug resistance is un-
known. Cell cycle redistribution after hypoxia does not seem
to be the main cause of this type of resistance, because no
significant difference was observed between aerobic control
cells and hypoxic cells after 10 h of hypoxia. Also, there was
no correlation with the development of ADR and 5-FU
resistance (Figure 3).
The P-glycoprotein-associated multidrug resistant pheno-
type has been shown to be associated with reduced drug
accumulation (Skovsgaard, 1978; Inaba et al., 1979; Sirotnak
et al., 1986). We investigated the ADR content of cells
exposed to increasing periods of hypoxia (Figure 6).
The ADR content decreased after 10 h of hypoxia. However,
the ADR content did not correlate with the development of
ADR resistance (Figure 3a), indicating that the decreased
ADR content in hypoxia-treated cells is not the main cause
of resistance to ADR. Our data also demonstrated that there
was no difference in the efflux rate of ADR between aerobic
cells and hypoxia-treated cells (Figure 7).
Hypoxia-induced ADR resistance has been proposed to be
related to the depletion of topoisomerase II which has been
observed to be caused by hypoxia or glucose starvation (Shen
et al., 1989). However, this hypothesis is not likely to explain
the development of hypoxia-induced resistance to 5-FU,
because the mechanism of action of 5-FU does not directly
involve topoisomerase II (Valeriote & Santelli, 1984). Two
observations may explain this observed resistance to 5-FU.
In hypoxic cells, the intracellular pools of nucleotides have
been found to be depleted (Loffier et al., 1983). Also, the
toxicity of 5-FU can be modulated by factors that regulate
the intracellular pools of phosphoribosyl phosphate (Ullman
& Kirsch, 1979). Continuous presence of oxygen is needed to
maintain the active, radical-containing form of ribonucleo-
side diphosphate reductase (Thelander et al., 1982). Thus, the
metabolism of 5-FU to 5-fluorodeoxyuridine monophos-
phate, which inhibits the enzyme thymidylate synthetase, may
be hindered in hypoxia-treated cells.
The overexpression of P-glycoprotein has been observed in
the classical form of multidrug resistance, with the degree of
resistance and the amount of P-glycoprotein greatly dimin-
ished in drug-sensitive revertants (Riordan & Ling, 1979).
However, we found no evidence of enhanced transcription of
mdr la and lb genes in hypoxia-treated cells.
The induction of oxygen-regulated proteins (ORPs) 33, 80,
100, 150 and 260 is triggered by hypoxic treatment and
correlated with the onset of hypoxia-induced drug resistance
(Shen et al., 1987; Wilson et al., 1989; Wilson & Sutherland,
1989). The kinetics of hypoxia-induced ADR and 5-FU resis-
tance in our results (Figure 3) also correlates well with the
kinetics of EMT6/Ro cell ORPs induction (Heacock & Suth-
erland, 1990). Upon reoxygenation, the synthesis rates of
ORPs declined rapidly and were correlated with the loss of
ADR resistance (Wilson et al., 1989; Wilson & Sutherland,
1989). These proteins may be involved in the development of
hypoxia-induced drug resistance. The nature and function of
the ORPs are under investigation in our laboratory.
In conclusion, hypoxia-induced drug resistance is different
from the classical multidrug resistance associated with P-
glycoprotein overexpression because of the lack of correla-
tion among cross-resistant drugs, the transient nature of
hypoxia-induced drug resistance (Figure 4), and the failure to
demonstrate an enhanced message for P-glycoprotein. The
presence of hypoxic cells in solid tumours that could generate
a multidrug-resistant phenotype may represent a significant
population resistant to some drugs.
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